Brief: Simcere Pharmaceutical Says Clinical Trial Approval Issued By NMPA
22/08/2024 14:31
Aug 22 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* CLINICAL TRIAL APPROVAL FOR SIM0508 (POLSMALL MOLECULE
INHIBITOR) ISSUED BY NMPA
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660